2023-05-012024-04-302024-04-30false11955391MAVERICKS TATTOO STUDIO LTD2025-01-3096090falseiso4217:GBPxbrli:pure119553912023-05-01119553912024-04-30119553912023-05-012024-04-30119553912022-05-01119553912023-04-30119553912022-05-012023-04-3011955391bus:SmallEntities2023-05-012024-04-3011955391bus:AuditExempt-NoAccountantsReport2023-05-012024-04-3011955391bus:AbridgedAccounts2023-05-012024-04-3011955391bus:PrivateLimitedCompanyLtd2023-05-012024-04-3011955391core:WithinOneYear2024-04-3011955391core:AfterOneYear2024-04-3011955391core:WithinOneYear2023-04-3011955391core:AfterOneYear2023-04-3011955391core:ShareCapital2024-04-3011955391core:SharePremium2024-04-3011955391core:RevaluationReserve2024-04-3011955391core:OtherReservesSubtotal2024-04-3011955391core:RetainedEarningsAccumulatedLosses2024-04-3011955391core:ShareCapital2023-04-3011955391core:SharePremium2023-04-3011955391core:RevaluationReserve2023-04-3011955391core:OtherReservesSubtotal2023-04-3011955391core:RetainedEarningsAccumulatedLosses2023-04-3011955391core:LandBuildings2024-04-3011955391core:PlantMachinery2024-04-3011955391core:Vehicles2024-04-3011955391core:FurnitureFittings2024-04-3011955391core:OfficeEquipment2024-04-3011955391core:NetGoodwill2024-04-3011955391core:IntangibleAssetsOtherThanGoodwill2024-04-3011955391core:ListedExchangeTraded2024-04-3011955391core:UnlistedNon-exchangeTraded2024-04-3011955391core:LandBuildings2023-04-3011955391core:PlantMachinery2023-04-3011955391core:Vehicles2023-04-3011955391core:FurnitureFittings2023-04-3011955391core:OfficeEquipment2023-04-3011955391core:NetGoodwill2023-04-3011955391core:IntangibleAssetsOtherThanGoodwill2023-04-3011955391core:ListedExchangeTraded2023-04-3011955391core:UnlistedNon-exchangeTraded2023-04-3011955391core:LandBuildings2023-05-012024-04-3011955391core:PlantMachinery2023-05-012024-04-3011955391core:Vehicles2023-05-012024-04-3011955391core:FurnitureFittings2023-05-012024-04-3011955391core:OfficeEquipment2023-05-012024-04-3011955391core:NetGoodwill2023-05-012024-04-3011955391core:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3011955391core:ListedExchangeTraded2023-05-012024-04-3011955391core:UnlistedNon-exchangeTraded2023-05-012024-04-3011955391core:MoreThanFiveYears2023-05-012024-04-3011955391core:Non-currentFinancialInstruments2024-04-3011955391core:Non-currentFinancialInstruments2023-04-3011955391dpl:CostSales2023-05-012024-04-3011955391dpl:DistributionCosts2023-05-012024-04-3011955391core:LandBuildings2023-05-012024-04-3011955391core:PlantMachinery2023-05-012024-04-3011955391core:Vehicles2023-05-012024-04-3011955391core:FurnitureFittings2023-05-012024-04-3011955391core:OfficeEquipment2023-05-012024-04-3011955391dpl:AdministrativeExpenses2023-05-012024-04-3011955391core:NetGoodwill2023-05-012024-04-3011955391core:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3011955391dpl:GroupUndertakings2023-05-012024-04-3011955391dpl:ParticipatingInterests2023-05-012024-04-3011955391dpl:GroupUndertakingscore:ListedExchangeTraded2023-05-012024-04-3011955391core:ListedExchangeTraded2023-05-012024-04-3011955391dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-05-012024-04-3011955391core:UnlistedNon-exchangeTraded2023-05-012024-04-3011955391dpl:CostSales2022-05-012023-04-3011955391dpl:DistributionCosts2022-05-012023-04-3011955391core:LandBuildings2022-05-012023-04-3011955391core:PlantMachinery2022-05-012023-04-3011955391core:Vehicles2022-05-012023-04-3011955391core:FurnitureFittings2022-05-012023-04-3011955391core:OfficeEquipment2022-05-012023-04-3011955391dpl:AdministrativeExpenses2022-05-012023-04-3011955391core:NetGoodwill2022-05-012023-04-3011955391core:IntangibleAssetsOtherThanGoodwill2022-05-012023-04-3011955391dpl:GroupUndertakings2022-05-012023-04-3011955391dpl:ParticipatingInterests2022-05-012023-04-3011955391dpl:GroupUndertakingscore:ListedExchangeTraded2022-05-012023-04-3011955391core:ListedExchangeTraded2022-05-012023-04-3011955391dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-05-012023-04-3011955391core:UnlistedNon-exchangeTraded2022-05-012023-04-3011955391core:NetGoodwill2024-04-3011955391core:IntangibleAssetsOtherThanGoodwill2024-04-3011955391core:LandBuildings2024-04-3011955391core:PlantMachinery2024-04-3011955391core:Vehicles2024-04-3011955391core:FurnitureFittings2024-04-3011955391core:OfficeEquipment2024-04-3011955391core:AfterOneYear2024-04-3011955391core:WithinOneYear2024-04-3011955391core:ListedExchangeTraded2024-04-3011955391core:UnlistedNon-exchangeTraded2024-04-3011955391core:ShareCapital2024-04-3011955391core:SharePremium2024-04-3011955391core:RevaluationReserve2024-04-3011955391core:OtherReservesSubtotal2024-04-3011955391core:RetainedEarningsAccumulatedLosses2024-04-3011955391core:NetGoodwill2023-04-3011955391core:IntangibleAssetsOtherThanGoodwill2023-04-3011955391core:LandBuildings2023-04-3011955391core:PlantMachinery2023-04-3011955391core:Vehicles2023-04-3011955391core:FurnitureFittings2023-04-3011955391core:OfficeEquipment2023-04-3011955391core:AfterOneYear2023-04-3011955391core:WithinOneYear2023-04-3011955391core:ListedExchangeTraded2023-04-3011955391core:UnlistedNon-exchangeTraded2023-04-3011955391core:ShareCapital2023-04-3011955391core:SharePremium2023-04-3011955391core:RevaluationReserve2023-04-3011955391core:OtherReservesSubtotal2023-04-3011955391core:RetainedEarningsAccumulatedLosses2023-04-3011955391core:NetGoodwill2022-05-0111955391core:IntangibleAssetsOtherThanGoodwill2022-05-0111955391core:LandBuildings2022-05-0111955391core:PlantMachinery2022-05-0111955391core:Vehicles2022-05-0111955391core:FurnitureFittings2022-05-0111955391core:OfficeEquipment2022-05-0111955391core:AfterOneYear2022-05-0111955391core:WithinOneYear2022-05-0111955391core:ListedExchangeTraded2022-05-0111955391core:UnlistedNon-exchangeTraded2022-05-0111955391core:ShareCapital2022-05-0111955391core:SharePremium2022-05-0111955391core:RevaluationReserve2022-05-0111955391core:OtherReservesSubtotal2022-05-0111955391core:RetainedEarningsAccumulatedLosses2022-05-0111955391core:AfterOneYear2023-05-012024-04-3011955391core:WithinOneYear2023-05-012024-04-3011955391core:Non-currentFinancialInstrumentscore:CostValuation2023-05-012024-04-3011955391core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-012024-04-3011955391core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-012024-04-3011955391core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-012024-04-3011955391core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-012024-04-3011955391core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-012024-04-3011955391core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3011955391core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3011955391core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3011955391core:Non-currentFinancialInstrumentscore:CostValuation2024-04-3011955391core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-3011955391core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-3011955391core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-3011955391core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-3011955391core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-3011955391core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-3011955391core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-3011955391core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-3011955391core:Non-currentFinancialInstrumentscore:CostValuation2023-04-3011955391core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-3011955391core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-3011955391core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-3011955391core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-3011955391core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-3011955391core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-3011955391core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-3011955391core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-3011955391bus:Director12023-05-012024-04-3011955391bus:Director22023-05-012024-04-30

MAVERICKS TATTOO STUDIO LTD

Registered Number
11955391
(England and Wales)

Unaudited Financial Statements for the Year ended
30 April 2024

MAVERICKS TATTOO STUDIO LTD
Company Information
for the year from 1 May 2023 to 30 April 2024

Directors

MOORE, Martin Nils
PAYNE, Ashley Thomas

Registered Address

C/O Xeinadin First Floor Secure House
Lulworth Close
Chandler's Ford
SO53 3TL

Registered Number

11955391 (England and Wales)
MAVERICKS TATTOO STUDIO LTD
Balance Sheet as at
30 April 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3528849
528849
Current assets
Cash at bank and on hand85,51556,368
85,51556,368
Creditors amounts falling due within one year4(30,011)(25,898)
Net current assets (liabilities)55,50430,470
Total assets less current liabilities56,03231,319
Net assets56,03231,319
Capital and reserves
Called up share capital100100
Profit and loss account55,93231,219
Shareholders' funds56,03231,319
The financial statements were approved and authorised for issue by the Board of Directors on 30 January 2025, and are signed on its behalf by:
MOORE, Martin Nils
Director
Registered Company No. 11955391
MAVERICKS TATTOO STUDIO LTD
Notes to the Financial Statements
for the year ended 30 April 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.
Revenue from sale of goods
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Office Equipment25
2.Average number of employees

20242023
Average number of employees during the year20
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 May 231,283
At 30 April 241,283
Depreciation and impairment
At 01 May 23434
Charge for year321
At 30 April 24755
Net book value
At 30 April 24528
At 30 April 23849
4.Creditors: amounts due within one year

2024

2023

££
Amounts owed to related parties22,41417,341
Taxation and social security6,6796,907
Accrued liabilities and deferred income9181,650
Total30,01125,898
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
5.Related party transactions
As at the year end, the directors Martin Moore & Ashley Payne were owed £16,347 (2023: £15,432) and £6,068 (2023: £1,908) respectively by the company.